摘要
就近期国内期刊陆续发表的中医药治疗新型冠状病毒肺炎(COVID-19)病例分析类文章(其中绝大部分为回顾性病例系列研究),鉴于此类研究本身的性质和存在的方法学局限,笔者从临床科研的角度,对无对照组的回顾性病例系列研究提出合理的设计要点和报告规范,以确保此类研究结果的可信度,避免结果或推论出现偏倚。
Recently a series of case-analysis articles have been published in Chinese Journals for traditional Chinese medicine treatment of coronavirus disease-2019(COVID-19).Most of them were retrospective case series study.Considering the characteristics and methodological limitations of such kinds of research,authors aimed to introduce reasonable methodological key points and reporting suggestions for uncontrolled retrospective case series study from the perspective of clinical research,thus to ensure credibility and avoid bias of the results.
作者
田紫煜
高颖
张颖
曹卉娟
费宇彤
刘建平
TIAN Zi-Yu;GAO Ying;ZHANG Ying;CAO Hui-Juan;FEI Yu-tong;LIU Jian-ping(Centre for Evidence Based Chinese Medicine,Beijing University of Chinese Medicine,Beijing,100029;Department of Neurology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing,100700)
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
2020年第9期1112-1116,共5页
Chinese Journal of Integrated Traditional and Western Medicine
基金
国家自然科学基金资助项目(No.81830115)。
关键词
新型冠状病毒肺炎
回顾性研究
病例系列
观察性研究
报告规范
coronavirus disease-2019
retrospective study
case series
observational study
reporting suggestions
